Atypical antipsychotics show a small link to liver disease in young patients

Doctors are watching how certain medicines affect the livers of children and adolescents. A recent look at three studies found a small connection between atypical antipsychotics and metabolic dysfunction-associated steatotic liver disease. These drugs are often used for mental health conditions. The review also noted that these medicines can raise obesity risks and cause liver toxicity in some cases. Risperidone specifically was linked to liver injury in the data. Using these drugs with more severe liver disease was also reported. The team looked at English language studies published between 1950 and 2020. They gathered data from 407 articles but only three met the strict rules for inclusion. The follow-up period covered 216 months. This long view helps understand long-term effects. However, the studies varied greatly in how they were done. Some had fair ratings while others were good. This mix makes it hard to draw firm conclusions. The results need careful interpretation because of these differences. This work serves as a foundation for future studies. It may help reform clinical guidelines for using these drugs in young people. The goal is to ensure patient safety while treating mental health issues.